Healthcare marketing is like going through a maze—there are so many turns and dead ends. You need to know the rules to find your way, and lately, the rules keep changing. The recent AHA v. Becerra case is one of those changes. Healthcare marketers saw this court decision as a potential win, offering a bit more flexibility for online tracking.
But before we celebrate, it’s important to remember that HIPAA compliance is still critical. Just because the rules have shifted doesn’t mean the risks are gone. In fact, HIPAA and healthcare marketing remain deeply connected, and ignoring the details could land your business in hot water.
The AHA v. Becerra case is about using online tracking tools in healthcare marketing. The American Hospital Association (AHA) pushed back against some parts of the OCR’s guide on tracking technologies that made it tougher for healthcare organizations to use popular marketing tools like Google Analytics and tracking pixels. These tools are crucial for getting insights into user behavior, but they also collect data under HIPAA regulations.
The court ultimately sided with the AHA. Their argument? The restrictions were too tight and hindered healthcare marketing efforts. The decision allowed for more flexibility in online tracking technology, which marketers saw as a win.
While the ruling in favor of the AHA relieves healthcare marketers, the real question is—what does this mean for HIPAA and healthcare marketing? The court’s decision might open some doors, but it doesn’t eliminate the need for strict compliance.
Tracking technologies can still capture sensitive data, and organizations remain at risk of violating HIPAA without proper safeguards.
The AHA v. Becerra ruling might seem like a win, but that doesn’t mean healthcare organizations are in the clear. Even with more flexibility, using tracking technologies in healthcare marketing still carries significant risks. You can’t brush aside HIPAA compliance—violations can happen without you knowing.
Tracking tools can capture more than you intend. IP addresses, patient browsing behavior, and appointment scheduling data can be considered Protected Health Information (PHI). Once PHI is collected, HIPAA requirements kick in. Without proper protection, you expose yourself to hefty fines of up to a couple of million dollars.
This is where HIPAA and healthcare marketing overlap—marketers must ensure their tools are compliant, no matter the ruling. Ignoring these risks could lead to severe consequences, both legally and financially.
When you use tracking tools like Google Analytics in healthcare marketing, you’re not just collecting clicks and page views—you might be picking up PHI without realizing it. Under HIPAA, PHI isn’t just names and medical records; it includes any data that can potentially identify a patient when combined with other info.
Here are some types of data tracking tools that can capture, among other HIPAA identifiers, that count as PHI:
Even though it might not look like you’re collecting sensitive info, these details can quickly add up and violate HIPAA. That’s why HIPAA and healthcare marketing must work hand-in-hand, ensuring you don’t accidentally gather data that puts your organization at risk.
On the surface, HIPAA and healthcare marketing might seem like two separate worlds, but they’re closely connected. Every marketing campaign—whether it’s a website, email blast, or social media ad—needs to stay HIPAA-compliant if there’s any chance it could involve PHI.
Here’s how they overlap:
It’s easy to think HIPAA doesn’t cover marketing, but in reality, they’re connected at every turn. HIPAA compliance should always be top of mind when using tracking technologies for healthcare marketing.
Google Analytics 4 (GA4) and Google Tag Manager (GTM) are key players in today’s healthcare marketing. They provide valuable insights into user behavior, helping you make smart, data-driven decisions. Just a heads-up, though—they’re not HIPAA-compliant.
GA4 and GTM can quickly gather sensitive data that counts as PHI under HIPAA. If you don’t have the proper measures in place, this data, for example, could end up on servers that aren’t HIPAA compliant. Even with the flexibility from the AHA v. Becerra ruling, these tools can still pose risks if you don’t take the necessary precautions.
So, while GA4 and GTM are essential, using them without a HIPAA-compliant setup is like sailing without a life jacket. The risks are real, and the overlap between HIPAA and healthcare marketing demands more than just a casual approach to these powerful tools.
In the end, no matter how much flexibility the AHA v. Becerra case brought, HIPAA compliance should always remain a top priority in healthcare marketing. Tools like GA4 and GTM are powerful, but if they’re not set up correctly, they could get you into trouble with HIPAA regulations.
This is where HIPALYTICS comes in.
We ensure that your GA4 and GTM setups are fully HIPAA-compliant. By anonymizing PHI and storing it securely on private, US-based servers, we help you use these tools safely, avoiding fines and consequences that can put your practice in trouble.
We know how often the HIPAA and healthcare marketing landscape shifts, so we keep ourselves updated and sign a BAA to protect you legally. With HIPALYTICS, you can rest easy knowing compliance is taken care of while enjoying advanced analytics’s full potential.
